U.S. flag

An official website of the United States government

NM_007078.3(LDB3):c.1603_1605delinsTGCCACTCA (p.Thr535delinsCysHisSer) AND Myofibrillar myopathy 4

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 12, 2018
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000816073.7

Allele description [Variation Report for NM_007078.3(LDB3):c.1603_1605delinsTGCCACTCA (p.Thr535delinsCysHisSer)]

NM_007078.3(LDB3):c.1603_1605delinsTGCCACTCA (p.Thr535delinsCysHisSer)

Gene:
LDB3:LIM domain binding 3 [Gene - OMIM - HGNC]
Variant type:
Indel
Cytogenetic location:
10q23.2
Genomic location:
Preferred name:
NM_007078.3(LDB3):c.1603_1605delinsTGCCACTCA (p.Thr535delinsCysHisSer)
HGVS:
  • NC_000010.11:g.86716698_86716700delinsTGCCACTCA
  • NG_008876.1:g.53135_53137delinsTGCCACTCA
  • NM_001080114.2:c.1273_1275delinsTGCCACTCA
  • NM_001171610.2:c.1618_1620delinsTGCCACTCA
  • NM_001368064.1:c.1414_1416delinsTGCCACTCA
  • NM_001368065.1:c.1414_1416delinsTGCCACTCA
  • NM_001368066.1:c.1462_1464delinsTGCCACTCA
  • NM_007078.3:c.1603_1605delinsTGCCACTCAMANE SELECT
  • NP_001073583.1:p.Thr425delinsCysHisSer
  • NP_001165081.1:p.Thr540delinsCysHisSer
  • NP_001354993.1:p.Thr472delinsCysHisSer
  • NP_001354994.1:p.Thr472delinsCysHisSer
  • NP_001354995.1:p.Thr488delinsCysHisSer
  • NP_009009.1:p.Thr535delinsCysHisSer
  • LRG_385t1:c.1603_1605delinsTGCCACTCA
  • LRG_385:g.53135_53137delinsTGCCACTCA
  • NC_000010.10:g.88476455_88476457delinsTGCCACTCA
  • NM_007078.2:c.1603_1605delACCinsTGCCACTCA
  • NM_007078.2:c.1603_1605delinsTGCCACTCA
Links:
dbSNP: rs1589675306
NCBI 1000 Genomes Browser:
rs1589675306
Molecular consequence:
  • NM_001080114.2:c.1273_1275delinsTGCCACTCA - inframe_indel - [Sequence Ontology: SO:0001820]
  • NM_001171610.2:c.1618_1620delinsTGCCACTCA - inframe_indel - [Sequence Ontology: SO:0001820]
  • NM_001368064.1:c.1414_1416delinsTGCCACTCA - inframe_indel - [Sequence Ontology: SO:0001820]
  • NM_001368065.1:c.1414_1416delinsTGCCACTCA - inframe_indel - [Sequence Ontology: SO:0001820]
  • NM_001368066.1:c.1462_1464delinsTGCCACTCA - inframe_indel - [Sequence Ontology: SO:0001820]
  • NM_007078.3:c.1603_1605delinsTGCCACTCA - inframe_indel - [Sequence Ontology: SO:0001820]

Condition(s)

Name:
Myofibrillar myopathy 4
Synonyms:
Myofibrillar myopathy, ZASP-related; Zaspopathy (type)
Identifiers:
MONDO: MONDO:0012277; MedGen: C4721886; OMIM: 609452

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000956563Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Oct 12, 2018)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000956563.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

Experimental studies and prediction algorithms are not available for this variant, and the functional significance of the affected amino acids is currently unknown. This variant has not been reported in the literature in individuals with LDB3-related disease. This variant is not present in population databases (ExAC no frequency). This variant, c.1603_1605delinsTGCCACTCA, results in the deletion of 1 amino acid and insertion of 3 amino acids of the LDB3 protein (p.Thr535delinsCysHisSer), but otherwise preserves the integrity of the reading frame. The LDB3 gene has multiple clinically relevant transcripts. The c.1603_1605delinsTGCCACTCA variant occurs in alternate transcript NM_007078.2 which corresponds to position c.*17324_*17326 in NM_001080116.1, the primary transcript listed in the Methods. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024